Nivolumab in Advanced Hepatocellular Carcinoma: Safety Profile and Select Treatment-Related Adverse Events From the CheckMate 040 Study.
Julien K, Leung HT, Fuertes C, Mori M, Wang MJ, Teo J, Weiss L, Hamilton S, DiFebo H, Noh YJ, Galway A, Koh J, Brutcher E, Zhao H, Shen Y, Tschaika M, To YY.
Julien K, et al. Among authors: noh yj.
Oncologist. 2020 Oct;25(10):e1532-e1540. doi: 10.1634/theoncologist.2019-0591. Epub 2020 Aug 24.
Oncologist. 2020.
PMID: 33400305
Free PMC article.